Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2024 ∙ Chirasuthat, S. Ratanapokasatit, Y. Thadanipon, K. Chanprapaph, K.
Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines among Patients with Immune-Mediated Dermatological Diseases: A Systematic Review and Meta-analysis
All age groups COVID-19 Efficacy/effectiveness Safety
Rating:
Low
2024 ∙ Sharifi Aliabadi, L. Azari, M. Taherian, M. R. Barkhordar, M. Abbas, S. A. M. Azari, M. Ahmadvand, M. Salehi, Z. Rouzbahani, S. Vaezi, M.
Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Low
2024 ∙ Muharam, R. Ika Putri, Y. Fitriayu Andyra, A. Ezekia, K. Elya Charilda, F. Bagastoro, A. Abigail Faradina, A. Pratama, G. Kemal Harzif, A.
Impact of COVID-19 Vaccination on In Vitro Fertilization Outcomes: A Systematic Review
All age groups COVID-19 Safety
Rating:
Critically low
2024 ∙ Man, M. A. Rosca, D. Bratosin, F. Fira-Mladinescu, O. Ilie, A. C. Burtic, S. R. Fildan, A. P. Fizedean, C. M. Jianu, A. M. Negrean, R. A. Marc, M. S.
Impact of Pre-Infection COVID-19 Vaccination on the Incidence and Severity of Post-COVID Syndrome: A Systematic Review and Meta-Analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Wu, Q. Zhang, P. Zhou, G. Fu, Q. Bai, R. Ding, H. Meng, F. Xu, X. Chen, M.
Impact of SARS-CoV-2 Vaccination or Infection on the Safety and Efficacy of Aesthetic Injections: A Systematic Review
All age groups COVID-19 Safety
Rating:
Critically low
2024 ∙ Padhi, B. K. Gupta, P. C. Al Kaabi, N. A. Al-Subaie, M. F. Alrasheed, H. A. Sulaiman, T. Rabaan, A. A. Khatib, M. N. Gaidhane, S. Zahiruddin, Q. S. Dziedzic, A. Satapathy, P. Fraj, N. J. Aldrazi, F. A. Kukreti, N. Rustagi, S. Abu Serhan, H.
Incidence and Association of Uveitis with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
All age groups COVID-19 Safety
Rating:
Low
2024 ∙ Yazdani, A. Mirmosayyeb, O. Sadeghi, M. Ghoshouni, H. Tavakol, G. Ghajarzadeh, M.
Incidence of Guillain-Barré Syndrome (GBS) after COVID-19 Vaccination: a Systematic Review and Meta-Analysis
All age groups COVID-19 Safety
Rating:
Critically low
2024 ∙ Muchangi, J. M. Mturi, J. Mukasa, H. Kithuki, K. Kosgei, S. J. Kanyangi, L. M. Moraro, R. Kamau, S. Nankanja, M.
Influence of government policies on handwashing and vaccine uptake in Kenya, Uganda, and Tanzania to prevent and control COVID-19: a systematic review
Africa Uganda All age groups COVID-19 Coverage
Rating:
Not applicable
2024 ∙ Del Riccio, M. Caini, S. Bonaccorsi, G. Lorini, C. Paget, J. van der Velden, K. Cosma, C.
Influenza vaccination and COVID-19 Infection Risk and Disease Severity: A systematic review and multi-level meta-analysis of prospective studies
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Morlanes Pallas, R.
Innate and adaptative immune mechanisms of COVID-19 vaccines. Serious adverse events associated with SARS-CoV-2 vaccination: A systematic review
All age groups COVID-19 Safety
Rating:
Critically low
Loading...